Clearstead Advisors, LLC
- SEC CIK
- 0000842775
- Latest filing
- Aug 6, 2026
GALT holding history
Galectin Therapeutics Inc in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GALT overviewAll 13F holders of GALTFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,000
- Value
- $27.8K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,000 | $27.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 6,000 | $16.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 6,000 | $25.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 6,000 | $25.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 6,000 | $12.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 6,000 | $7.32K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 6,000 | $7.74K | <0.1% | +3,000+100.0% | Added | Holders |
| Q3 2024 | 3,000 | $8.25K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,000 | $6.78K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,000 | $9.24K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,000 | $4.98K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,000 | $5.76K | <0.1% | +1,500+100.0% | Added | Holders |
| Q2 2023 | 1,500 | $2.16K | <0.1% | +1,500 | New | Holders |